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The use of sodium citrate as an anticoagulant for 
blood was known to physiologists during the last part of 
the 19th century, but this knowledge did not receive 
clinical application until the time of World War I. Hustin, 
a Belgian, in 1914 published reports of the citrate method 
as tested in a series of animal experiments, and applied it 
successfully in the first recorded case of human blood 
transfusion using citrate as an anticoagulant (24), In 
the following year Lewisohn (21,22), a New York surgeon, 
and Agote (24), an Argentinian, independently published 
additional results of indirect transfusions by the citrate 
method. Other techniques of blood transfusion immediately 
became obsolete; and Bernheim (24), a prominent Baltimore 
surgeon of that period, remarked that citrate made trans¬ 
fusion available throughout the world in all ranks and 
"nothing but knocked into a cocked hat great transfusion 
specialists like me and others who could be mentioned," 
Lewisohn found that an 0,1# concentration of sodium 
citrate in blood in vitro does not delay clotting but that 
a 0.15# concentration will allow fluidity for at least two 
days (21,22). He therefore advocated the use of a 0,2# 
concentration of citrate in blood as an effective and non¬ 
toxic level for transfusion. Citrate alone proved to be 
inadequate for the preservation of blood for very many days, 
and it was found that hemolysis would be greatly delayed by 









alkaline reaction, and in view of the reports that the red 
cells are better preserved in a slightly acid medium, a 
solution containing sodium citrate, glucose, and citric acid 
(A-C-D solution) came into use. This A-C-D solution has a 
pH of 4.9 which is raised to pH 6.5 or more by the ad¬ 
dition of blood (16). 
The effect of sodium citrate on serum calcium was 
first postulated by Sabatini (17) who believed that calcium 
citrate was formed and that it was an unionized compound. 
He later suggested that the anticoagulant action of citrate 
was due to the depression of ionized calcium required for 
clot formation (31). Hastings et al (14) presented sup¬ 
porting physicochemical evidence to show that when calcium 
and citrate are present in solution, a part of the calcium 
is bound in the form of a complex ion, and that the primary 
dissociation constant of calcium citrate is relatively high 
(pK of 3.22). This concept of the mechanism of clot pre¬ 
vention was generally accepted until Quick and Stefanini 
(17,29) proposed that the primary anticoagulating action 
of sodium citrate, as opposed to oxalate, in the concentra¬ 
tions used clinically, was not decalcification but anti- 
prothrombic by the formation of a prothrombin-citrate com¬ 
plex in the presence of an appreciable amount of calcium 
ions. Milstone (26) states that while the existence of a 
prothrombin-citrate complex has not been confirmed or denied, 
the evidence presented by Quick and Stefanini is as yet 








Frora time to time citrate has been suspected of being 
a cause of transfusion reactions. With the increasing know¬ 
ledge, however, of blood-group incompatabilities- and real¬ 
ization of the hazards of pyrogenic contamination of solu¬ 
tions and equipment, citrate has been cleared of many of the 
accusations leveled against it in the past. The widespread 
clinical use of blood, and especially the practice of in¬ 
fusing large quantities of plasma and blood for the preven¬ 
tion and treatment of shock following trauma during World 
War II, have firmly established citrate as a safe and 
technically satisfactory anticoagulant for blood transfusion. 
It is well known that the train of symptoms following the 
administration of sodium citrate and citric acid in toxic 
quantities appears to be identical with that of calcium ion 
deficiency consisting of increased general activity, hyper- 
pnea, peripheral vasodilitation, salivation, muscle twitching 
clonic and tonic convulsions, cyanosis, (Jheyne-Stokes respira 
tion, and occasional death (12). The toxicity of rapidly 
administered citrate depends on the quantity given and the 
rate of administration (1,12,15,19,27,32,33,35). Citrate 
reduces the calcium. Ion concentration of the plasma by 
forming a soluble but weakly ionized complex with calcium 
(14). Saffran and Denstedt (32) observed that when citrate 
is injected rapidly in small doses into rabbits, the ionized 
calcium of the plasma is depressed momentarily; and the 
release of calcium ions from the plasma proteins is so rapid 
that it Is impossible to obtain a blood sample quickly enough 
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to demonstrate any change in the calcium ion concentration* 
No effect could be demonstrated except when a concentrated 
solution of citrate was injected sufficiently rapidly to 
produce convulsions. Even under these circumstances the 
calcium ion concentration in the blood was rapidly restored 
and a complete recovery was made within 5 minutes. 
Minot et al (27) believed that conditions in which 
one might expect the administration of citrate to be un¬ 
desirable or unusually toxic are those in which the effect 
of calcium is reduced by the presence of some antagonistic 
substance or in which there is an actual reduction of total 
calcium, or those, such as alkalosis, in which the degree 
of calcium ionization is diminished. They reasoned that the 
introduction of citrated blood causes a dilution of the 
recipients blood with a solution containing few free calcium 
ions while excess citrate not already combined with the 
calcium in the donor's blood further reduces its calcium ion 
concentration. Upon administration of compatible citrated 
blood into parathyroidectomized dogs and into normal dogs 
made alkalotic by sodium bicarbonate, a reaction typical of 
acute lack of calcium was observed which could be relieved 
or prevented by the intravenous injection of calcium salts. 
Krautwald and Dorow (19) observed in humans what was 
shown by other investigators in animal experiments. They 
noted that tetany appeared in human subjects following the 
rapid introduction of 5 grams of sodium citrate intra¬ 










of onset and the severity of the symptoms varied with the 
dose and rate of administration. 
Among clinical situations which would involve the 
rapid administration of citrate are exchange transfusions in 
infants with erythroblastosis fetalis, massive hemorrhage 
requiring replacement transfusion, and the use of concen¬ 
trated plasma solutions in which the citrate used for anti¬ 
coagulation has also been concentrated. Hill and Muirhead 
(15) reported citrate reactions in 4 patients (3 children, 
and 1 young adult with hypocalcemia) upon rapid administra¬ 
tion of a concentrated plasma and citrate solution. The 
reactions could be prevented or terminated at will by the 
injection of calcium chloride or gluconate solutions. 
During recent years exchange transfusion has become a 
standard procedure in the treatment of erythroblastosis 
fetalis (6,30,38,39). Hypocalcemic tetany (6), hyper¬ 
calcemia (38), and fatalities (30,38,39) have been described 
following the use of citrated blood for this condition. 
Wexler et al (38) reported the case of an infant whose plasma 
calcium rose from an initial level of 10.0 mgm,% to 15.3 mgm*$ 
after only 180 c.c. of blood had been transfused. Death 
followed in 24 hours and post mortem examination of the liver 
showed severe necrosis. Rosenblatt (30) described massive 
liver necrosis in 3 infants who also died after exchange 
transfusion. 28 cases of erythroblastosis fetalis treated 
by exchange transfusions, including 7 deaths, were reported 
by Wiener and Wexler (39) who acknowledged the suggestion 
' . 
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that the infants who died succumbed to the effects of large 
amounts of citrate as the anticoagulant in the transfused 
blood. They felt, however, that the deaths occurred in spite 
of rather than because of treatment. 
The fate of administered citrate is suggested by 
several experimental studies on animals which indicate that 
it is metabolized by most tissues, notably renal cortex (9), 
liver (34), and muscle (38), and it is stored in bone (7). 
When citrate is given parenterally or by mouth, the greater 
portion of it is oxidized to carbon dioxide and water (9), 
Some of it may be converted to glycogen, or at least it has 
a glycogenic effect on the liver (38). Although the kidney 
is capable of concentrating and excreting citrate, Freeman 
and Chang (10) have observed a spontaneous increase in the 
serum calcium and plasma citrate levels in bilaterally 
nephrectorn!zed dogs 24 hours postoperatively. Citrate given 
intravenously to these nephrectorn!zed animals caused an 
elevation of the plasma citrate level which persisted for 
2 to 3 days. Conversely, bilateral ureteral ligation alone 
failed to cause any significant rise in the serum calcium or 
plasma citrate, nor did it interfere with the rapid removal 
of citrate given intravenously. They therefore concluded 
that the renal parenchyma is the principal site of removal 
of circulating citrate. 
Various animal studies have been undertaken by numer¬ 
ous investigators to determine the effect of citrate on the 












intravenously in 3% solution to 2 normal dogs at the rate of 
100 mgm. per Kg. of body weight in approximately 30 minutes 
and observed decreases in the plasma calcium from 12.1 to 
9.6 and 11.5 to 10.1 mgm./ from a pre-injection control to a 
second sample taken one half hour after injection. Recovery 
was nearly complete in a few hours. Administration of the 
same solution to thyro-parathyroidectomized dogs at rates 
varying from 87 mgm./Kg. in 11 minutes to 126 mgm./Kg. in 
36 minutes resulted in slower falls in the plasma calcium, 
and in no case was recovery in these animals complete in 
24 hours. Chang and Freeman (5) administered a 2.5/ citric 
acid solution (neutralized to pH 7.4 with sodium hydroxide 
before injection) intravenously to normal dogs at the rate 
of 40 mgm./Kg./hr. for 2 hours and observed an average rise 
in serum calcium from 10.87 mgm./ to 11,80 mgm./ associated 
with an increased average urinary calcium excretion of from 
0.39 mgm./hr. to 8,91 mgm,/hr. 
Mylon and his colleagues (28) also found a significant 
rise in the serum calcium values in their dogs, using a 2.5/ 
sodium citrate solution, and noted that it was associated 
with a moderate hemoconcentration, as evidenced by a rising 
hematocrit, and a marked loss of plasma protein. Notwith¬ 
standing the increase in total calcium, the animals showed 
signs of tetany which were promptly relieved by injection 
of small amounts of ionized calcium. 
Bruneau and G-raham (4) reported experiments in which 

















The blood was reinjected after each bleeding* and the re¬ 
injected blood contained either heparin or a 0.6$ concentra¬ 
tion of sodium citrate. The bleedings and replacements were 
continued until the animals died. The dogs receiving citrated 
blood expired after an average of 9.25 bleedings, or after a 
total of 92.5$ of the estimated blood volume had been with¬ 
drawn and reinjected, while the dogs receiving the heparinized 
blood died after an average of 25.2 bleedings, or after a 
total of approximately 252$ of the estimated blood volume 
had been withdrawn and replaced. The dogs in the citrate 
group showed signs of tetany associated with substantial 
rises in the serum calcium, whereas the heparinized group 
showed no serum calcium changes and no signs of tetany. 
By giving a slow intravenous injection of 1.5$ sodium citrate 
solution, Bruneau and Graham (4) observed a fall in total 
serum calcium thus confirming the work of Tsai and Hsu (37) 
and in contrast to the increase in calcium noted in their 
exsanguination experiments. 
Hastings (13) has stated that when citrate is injected, 
not only the ionized calcium but also the calcium of calcium 
proteinate combine with it to form a complex calcium citrate 
ion, and the total calcium remains the same. He found, as 
did Freeman and Chang (10), that if the kidneys and liver 
were tied off, calcium was drawn from the body stores to 
replace the depleted ionized fraction and the total blood 
calcium was increased. 
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injection of 8-30 c.c./Kg. of a 4$ sodium citrate solution 
into dogs over a 7 hour period caused a considerable and 
prompt incres.se in the urinary excretion of calcium while 
leaving the blood calcium essentially unaffected, and in¬ 
dicating that a mobilization of calcium must have occurred. 
Evidence that calcium is mobilized from bone stores is 
provided by the observation that repeated subcutaneous in¬ 
jection of citrate into puppies and young rats led to os¬ 
seous changes very similar to those produced by large doses 
of parathormone (11). Additional support comes from the 
work of Lansing and Scott (20) who demonstrated with the 
electron microscope and microincineration techniques that 
calcium and magnesium are removed from the nucleus, cyto¬ 
plasm, and cell membranes of muscle, nerve, and soft tissue 
cells perfused with sodium citrate solution. 
Very little information is available in regard to the 
effect of citrate as it is used clinically in humans. 
Krautwald and Dorow (19) report that the total serum calcium 
does not change as a result of citrate administration, but 
their observation is based on the rapid injection of a large 
amount of sodium citrate (5 grams) within a few minutes, 
Ames and his colleagues (3) did electrocardiographic studies 
on infants receiving citrated plasma and demonstrated a 
prolongation of the Q-T interval, either compared with normal 
standards or relative to the initial value of the infants, 
such as one would expect with a lowered calcium ion concen¬ 
tration. They reported that the concentration of calcium 





ions fell as the plasma citrate level rose, and that there 
was a lack of parallelism between the citrate level and the 
prolonged Q-T interval. It was observed that the Q-T inter¬ 
val tended to return to normal despite the persistence of 
elevated citrate levels, and this was taken as evidence for 
the existence of factors counteracting the decrease of 
ionized calcium in the plasma. While this conclusion ap¬ 
pears to have some validity in the light of evidence gleaned 
from animal experiments, their work is subject to the 
criticism that their calcium ion values were determined from 
the nomogram of Hastings and McLean (25), assuming that the 
total protein and total calcium did not change during the 
infusions. Such an assumption cannot be lightly made when 
one considers the contradictory data of other investigators 
(4,5,28,37) and Mylon’s observation (28) that citrate causes 
a fall in plasma proteins. Wexler et al (38) report a single 
case of erythroblastosis where calcium values were studied 
during the exchange transfusion, and describe a rise in the 
serum calcium before the administration of calcium gluconate. 
On the basis of their work on dogs, Bruneau and Graham 
(4) prescri.be caution against the too liberal clinical use 
of citrated blood in transfusions. To duplicate their exper¬ 
iment in man, a 70 Kg. individual would have to be given 
6300 c.c, of blood containing 0.6$ citrate within a few 
hours. However, bank blood only contains approximately 
half that concentration of citrate. Ivy and his colleagues 











45-70%of their total blood volume by massive hemorrhage, 
whereas 50% of 50 animals dies after a loss of 45-83$! re¬ 
placed with 0.25% citrated blood within 5 minutes, and only 
5% of 50 animals died after a 45-78% loss replaced with 
heparinized plasma (20 mgm./L.) within 5 minutes. They 
calculated that 1500 to 2500 c.c. of citrated blood or plasma 
given rather rapidly to a 70 Kg. man after a massive hemor¬ 
rhage might prove to be fatal, and felt that the high tox¬ 
icity of citrate under their experimental conditions repre¬ 
sented a contraindication for the clinical use of citrate 
as an anti coagulant in the replacement of extensive hemor¬ 
rhage. Adairs and his co-workers (1) on the other hand found 
that massive transfusions of citrated blood were safely 
tolerated by dogs for the treatment of extreme shock (BP of 
30-45 mm. Eg) produced by hemorrhage of as much as 60% of 
the estimated blood volume when replacement of blood loss 
was made during a period of 20 minutes or longer. Calcium 
gluconate was very effective in preventing or alleviating 
citrate intoxication when very large doses of citrate had 
been administered during a short period of time. When 
bleeding and transfusion were conducted simultaneously, an 
average of 112% of the estimated blood volume was exchanged 
during a period of 70 minutes before the animal expired. 
Vi/hen the rate of bleeding and transfusion was less rapid 
a larger volume could be exchanged. To duplicate their 
results in a 70 Kg. man, 7840 c.c. of citrated blood would 







experiments Thornton et al (35) found that if shock is 
avoided, a dog’s blood volume may be depleted by bleeding 
and replaced by transfusion as many as ten times without 
ill effects using heparinized blood. However dogs usually 
die if the same procedure is carried out using citrated 
blood, even though calcium gluconate is added. This was 
thought to be due to the overloading of the blood stream 
by the large volume of fluid used to convey the citrate 
with resultant pulmonary edema. To test the validity of 
this hypothesis, three animals were given an amount of 
physiological saline equivalent to the volume of citrate 
solution used as an anticoagulant in the replacement trans¬ 
fusion. 1 dog died and post mortem examination revealed 
acites and pulmonary edema. There was no mention of any 
changes in the liver. Because it was unlikely that these 
experimental conditions would ever be approached clinically, 
Adams and Thornton (1,35) felt that a large margin of safety 
was present even with the use of massive transfusions of 
citrated blood or plasma. Gruber and Halbeisin (12) concur 
in this view; and, on the basis of LD^q investigations in 
animals, estimate that about 1 liter of anticoagulant A-C-D 
solution alone would have to be given to a 70 Kg. man in 
15 minutes or less in order to cause death in 50 % of the 
patients so treated. 
Clinical experience with citrate transfusions seems to 
indicate that it is a relatively non-toxic anticoagulant, 








approximately 34 grains of citrate in 7500 c.c. of citrated 
blood in a 6 hour period with little or no reaction. Allen 
et al (2) presented detailed information on 53 patients who 
received massive transfusions of from 1500 to 6000 c.c. of 
citrated blood and/or plasma in from 2 to 6 hours during 
operations. In spite of Ivy’s estimation (18) that the 
rapid administration of from 7.5 to 20 grams of citrate 
might prove fatally toxic, 9 of the patients in this study 
received 20 grams or more of citrate without incident in¬ 
cluding one who had been given 41 grams in 4.5 hours. In 
addition, most of these patients weighed less than 70 Kg. 
The transfusion period of 2 to 6 hours was sufficiently 
long to permit considerable metabolism and excretion of 
citrate, and thereby any cumulative toxic effect of the drug 
was prevented. It was concluded that the risk of citrate 
poisoning associated with the administration of large trans¬ 
fusions is negligible as currently practiced (2). f&iatever 
the properties of citrate may be, it is apparently detoxified 
rapidly enough so that It does not present a problem in the 
use of massive transfusions in man. Not only did the patients 
in this series tolerate their transfusions well, but without 
the liberal use of blood or plasma most of these radical 
procedures could not have been carried to a successful 
conclusion. 
Although the use of citrate as an anticoagulant Is 
a well established and safe technique and of great importance 
in many types of medical and surgical treatments, there is a 
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paucity of information in the literature concerning the 
effect of citrate on calcium as observed in humans. The 
purpose of this study is to determine the effect on the 
total calcium of citrate used clinically in the form of 







A-C-D solution (Table I) was employed as the anti¬ 
coagulant, and the citrated blood used in this study was 
collected and prepared by the blood bank in the usual fashion. 
Table I 
A-C-D Solution 
(A-C-D Solution B, U.S.P. XIV) 
Each 100 c.c. contains: 
Sodium citrate 1.32 gm. 
Citric acid 0.48 gm. 
Dextrose 1.47 gm. 
This consisted of aspirating blood from the vein of the 
donor into a vacuum bottle containing 120 c.c. of A-C-D 
solution until the 600 c.c. mark had been reached. There¬ 
fore, citrated blood represented a dilution of 4 volumes of 
whole blood with 1 volume of anticoagulating fluid. The 
final concentration of sodium citrate and citric acid in 
the preserved blood was 0,36%. 
A special solution hereafter called citrate infusion 
was prepared using the same proportions but substituting a 
3% glucose solution for the undiluted blood. 
Methods 
In this investigation 26 patients, randomly selected, 
were divided into 3 groups. Group I consisted of 10 patients 
who underwent various major thoracic and abdominal surgical 
procedures and received 2.5 to 5.5 units of citrated blood 
during the operations. Blood samples were drawn for total 
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serum calcium determinations before commencement of surgery, 
and generally after the induction of anesthesia; after the 
wound had been closed and before the patient was moved from 
the operating table; and once or twice during the procedure 
if possible* In each case blood was being infused at the 
time the last sample was drawn. 
Group II consisted of 10 patients who were in bed and 
were given 2000 c.c. of citrate infusion intravenously. 
This volume of solution contained an amount of A-C-D solution 
equivalent to that contained in 3.33 units of citrated blood. 
Blood samples were drawn for total serum calcium determinations 
before the start of the infusion, after approximately 1000 
c.c. had been given, and immediately after completion of the 
infusion. 
Group III consisted of 6 patients who underwent 
herniorrhaphy or gastrostomy operations of such nature that 
the administration of citrated blood was unnecessary as part 
of the operative management. Blood samples were drawn using 
the same schedule as for Group I. 
For calcium determinations venous blood was collected 
under oil in chemically clean tubes. The serum was separated 
by centrifugation and pipetted off within 1 hour after col¬ 
lection. The total serum calcium concentration was deter¬ 
mined either by use of the flame photometer, or by the method 
of Kramer and Tisdall (36) as modified in the Laboratory of 
Medical Chemistry of the Grace-New Haven Community Hospital. 
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within 5$ of each other in almost every case. 
Results 
The patients in Group I received from. 2.5 to 5.5 
units of citrated blood containing 5.4 to 11.9 grains of 
citrate in a maximum of 315 minutes. The changes in serum 
calcium observed (Tab. II, Figs. 1-2) revealed substantial 
variations from the initial levels in 7 cases where the 
amount of citrated blood given varied from 2.5 to 4.3 units. 
Administration of 2.5 units in one case was associated with 
a post-operative fall in calcium of 12.9$. An initial rise 
of over 15$ was seen in the patient who received 4.3 units 
and was followed by a fall of 16.1$ before reaching a final 
value only 3.3$ greater than the pre-citrate level. The 
fluctuations in the remaining cases were of a lesser 
magnitude and not over 10$ except for a decrease of 11.4$ 
between 2 successive determinations in a patient who re¬ 
ceived 3 units. Differences of less than 3$ were noted in 
2 patients who received 5.5 units and 1 who received 5 units 
of citrated blood. Rate of administration did not affect 
the magnitude or direction of the calcium response. 
Each patient in Group II (Tab. Ill, Figs. 3-4) re¬ 
ceived 2000 c.c. of citrate infusion containing 7,2 grams 
of citrate in from 145 to 260 minutes. Initial decreases 
in serum calcium were observed in 9 cases which were fol¬ 
lowed by subsequent continued decreases in 7 cases to reach 
a low level of -13$, in one instance, as compared with the 
control value. The initial rise in the 10th case was 
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85 10.90 /0.5 2.5 5.4 24 
165 10,65 -1.8 
240 9.45 -12.9 
C26856 0 9.65 
10* 
85 9,25 -4.1 
175 9,95 /3.1 3.0 6.5 21 
265 8.85 -8.3 
325 8.90 -7.8 
386917 0 10.50 
5* 
90 12.10 /15.2 4,3 9,4 37 
180 10.40 -0.9 





115 8.32 -9.3 2,5 5,4 19 
320 8.53 -7,0 
397894 0 8,73 
95 9.28 /6»3 3.5 7,6 
160 9.20 /5.4 
225 9.31 /6.5 
399223 0 10.14 
110 9,42 -7,1 2.5 5.4 
240 9.46 -6.7 
390153 0 8.82 
15* 5.5 11,9 55 
230 8.61 -2,4 
398154 0 9.84 ' 
100 9.98 /l, 4 5.5 11.9 
160 9.79 -0,5 
240 9.88 /•0,4 
A39581 0 10.60 
30* 
80 10.45 -1,4 3.0 6.5 31 
170 11.35 /7.1 
240 10.50 -0.9 
C60676 0* 9.65 
95 9,71 /0.6 5.0 10.8 39 
150 9.64 -0,1 
275 9.80 /l«6 • 







































































Patient Time, Serum Ca -%- Citrate 
No. min. mgm. °/0 Change mgm./min. 
A29353 0 9.75 
135 9.54 -2,8 31 
235 9.32 -4.4 
A14914 0 9.72 
155 9.62 -1.0 28 
260 9.52 -2.1 
397142 0 8.82 
125 8.44 -4.3 31 
235 8.34 -5,4 
397695 0 9.36 
125 8.79 -6.1 33 
320 8.14 -13,0 
397426 0 10.94 
110 10.26 -6,2 50 
145 9.85 -10.0 
B70437 0 10.70 
110 10.47 -2.1 35 
205 9.69 -9.4 
385890 0 9,96 
125 9.38 -5.8 36 
200 11.01 /10.5 . 
385664 0 11.21 
120 10.21 -8.9 35 
205 9.86 -12.0 
B78106 0 10.05 
110 9.78 -2.7 35 
205 10.62 /5.7 
A21945 0 10.90 
100 10.96 /0.6 29 
245 9.81 -10.0 
followed by a decrease to a level 10% below the pre-infusion 
value. Post-infusion increases were noted in only 2 cases. 
As was observed in Group I the rate of administration did 
not seem to influence either the magnitude or direction of 
the calcium response. 
The 6 patients in Group III (Tab. IV, Figs. 5-6) did 
not receive citrate in any form, but were exposed to the 






















































Patient Time, Serum Ca Jo- 
No. min. mgm. % Change 
385664 0 10.87 
80 9.93 -8,7 
398168 0 9.38 
40 9,41 /0.3 
90 9.42 /0.3 
A29353 0 9.84 
165 9.42 -4,3 
B70437 0 9.74 
125 9.22 -5.3 
190 9.50 -2.5 
C46440 0 9.80 
110 10.08 /3,0 
A74504 0 "10.95 
60 10.60 -3,2 
125 10.75 -1.8 
150 10.45 -4,6 
were observed in 4 cases with a maximum fall of 8.7$. 
A rise of 3$ was found in one instance, and the fluctuations 
in the remaining case were so slight as to be considered 
insignificant. The changes in calcium showed no correlation 
to the length of the surgical procedure. 
There v/ere no signs or symptoms suggestive of 
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DISC US SI ON 
The results of this investigation indicate that the 
administration of citrate infusions alone, and in the ab¬ 
sence of other variables, will result in a slight fall in 
the total serum calcium. It can be seen In Figure 4 that 
the general tendency of calcium fluctuation in Group II 
was in the negative direction. An infusion of 5% glucose 
solution does not affect the serum osmolarity (8), and 
’would therefore be unlikely to cause any change in serum 
calcium. The citrate infusions given to the patients in 
Group II consisted of citrate solution added to a 5% glucose 
solution. Thus the assumption is made that the changes 
in serum calcium can be attributed to the effects of the 
citrate. A similar tendency toward a decrease In calcium, 
although of a lesser magnitude, was noted in Group III where 
the only responsible factors were the stresses of surgery 
and anesthesia. Group I was exposed to the influences of 
both an operative procedure and citrate In the form of 
citrated blood, and in Figure 2 no consistent pattern of 
fluctuation can be seen. Those patients who received the 
most blood (5.0-5.5 units) showed the least changes. 
Injected citrate combines with calcium Ions in the 
serum to form'a complex calcium citrate ion which is rapidly 
excreted (13). If the citrate is not introduced at too 
rapid a rate, the concentration of ionized calcium is 
restored by the release of calcium ion from the plasma 




(32), The Increased calcium excretion provoked by citrate 
would tend to deplete the intravasculer supply were it not 
for the fact that release of calcium from endogenous stores 
tends to replace the loss. That this does occur is evi¬ 
dent from the work of G-omori and Gulyas (11) who demonstrated 
that repeated injections of citrate over a period of time 
mimics the changes produced by large doses of parathormone. 
The minimum length of time required for mobilization of 
calcium from body stores after depletion by citrate is still 
obscure, although Lansing and Scott (20) have shown that 
only a very short time is necessary at least for non-osseous 
tissues. It is possible that mobilization is responsible 
for the long-term restoration of the serum calcium level; 
but that short-term increases are due to hemoconeentration 
caused by citrate, as shown by Mylon, Winternitz, and 
de Suto-l\fagy (28), However, since even the latter workers 
noticed a substantial rise of from 11,3 mgm.$ to 13.8 mgm./£ 
in one of their dogs in the absence of any hematocrit 
change, it appears that the theory of rapid mobilization 
is the more likely explanation. 
If the validity of such a theory is assumed, it is 
possible that the maintenance or Increase in calcium results 
either from the effect of citrate directly, before it is 
metabolized and excreted, or indirectly through the mediation 
of some other organ, Tsai and Hsu (37) showed that para¬ 
thyroidectomy greatly interferred with the ability of a dog 
to restore its serum calcium to the initial levels after 
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decreases following citrate injection. This implies that 
citrate exerts its effect indirectly by either inducing a 
fall in the serum calcium which stimulates the parathyroid, 
or by exerting a stimulating effect of its own on the para¬ 
thyroid. There is not sufficient evidence at the present 
time to resolve this question. 
Although urinary excretion was not measured in this 
study, it is nevertheless likely that the decreases observed 
in serum calcium in Group I reflect losses by way of the 
kidney. In 2 cases in this group, points were reached 
where the calcium levels stopped falling and began to rise 
sharply. In 1 of the patients referred to, a rise of 16.3$ 
as compared with the initial value was noted in 75 minutes. 
The most likely explanation for such a rise is that the 
patient's threshhold for either citrate or hypocalcemia 
had been reached resulting in parathyroid stimulation 
and release of calcium from body stores to the intravascular 
space. It may be that these patients had low threshholds 
for citrate and the changes induced by it; and that if the 
period of citrate administration and observation had been 
continued, similar Increases might have been manifested 
by the 8 remaining patients in the group with higher thresh¬ 
holds . 
Any affect of citrate given In the form of citrated 
blood to patients in Group I must have been masked by the 
complicating variables of the surgical procedure. That 
this is indeed a potent factor is apparent from the changes 








in patients who did not receive any citrate. The kinds 
of operations performed on the patients in Group I were 
more extensive than the herniorrhaphies and gastrostomies 
done on Group III: large body cavities were opened and 
fluid losses were greater. The fluctuations in calcium 
values resulting from these changes in fluid balance 
prevent any interpretation of the results In Group I 




1. Intravenous citrate causes an Initial decrease 
in the serum calcium level occasionally followed by a 
sharp rise which might be the manifestation of a low- 
threshhold response. 
2. The results of this investigation corroborate 
previous observations that citrate is a relatively non¬ 
toxic anticoagulant as it Is currently used clinic ally. 
No reactions to citrate were noted in the 20 patients 
who received it during the course of this study. 
' 
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